Movement Alert|Synopsys Rises 3.17% in Regular Trading, Elliott Representative Joins Board as Multiple Institutions Raise Target Prices

Market Focus
06/02

On June 2, Synopsys rose 3.17% in regular trading, trading at $490.59/share, with trading volume of $690 million. The stock rebounded after experiencing an 8.6% decline following its Q2 earnings release.

On the news front, activist investor Elliott Investment Management's representative Jesse Cohn officially joined Synopsys' board of directors effective June 1, expanding the board to 11 members. Under the cooperation agreement, Elliott has committed not to increase its stake beyond 4.9% and has agreed to customary standstill, voting, and confidentiality provisions.

Simultaneously, multiple institutions raised their target prices following the Q2 earnings report. Citi raised its target to $610 maintaining a Buy rating, Rosenblatt raised to $575 maintaining Buy, and HSBC raised to $490. The average analyst target price stands at $561.81 with an overweight consensus rating. The combination of governance optimization expectations from Elliott's board entry and institutional bullish consensus provided a catalyst for the stock to stabilize and rebound after its post-earnings selloff.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10